UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004228
Receipt number R000005083
Scientific Title Effects of BanxiaHoupuTang for swallowing disorder and prevention of aspiration pneumonia in brain damaged patients
Date of disclosure of the study information 2010/10/31
Last modified on 2012/03/17 10:19:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of BanxiaHoupuTang for swallowing disorder and prevention of aspiration pneumonia in brain damaged patients

Acronym

HT for swallowing reflex and prevention of pneumonia in brain disease

Scientific Title

Effects of BanxiaHoupuTang for swallowing disorder and prevention of aspiration pneumonia in brain damaged patients

Scientific Title:Acronym

HT for swallowing reflex and prevention of pneumonia in brain disease

Region

Japan


Condition

Condition

post cerebrovascular disease, neurodegenerative diseases e.g. PD, SCD, ALS

Classification by specialty

Medicine in general Neurology Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of BHT for swallowing refles disorder and preventing aspiration pneumonia in brain disease patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

wallowing reflex, pneumonia onset

Key secondary outcomes

days with fever over 37.5, self-feeding


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Taking BHT (traditional Chinese medicine) 8weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1.elderly patients with brain diseases
2.Swallowing reflex can be tested
3.Aspiration pneumonia history at least 1 time
4.Transaminases are less than twice of w.n.l.
5.Cre less than 2.0
6.Stable status and will survive more than 3 months after baseline
7.With informed concent and agreement from patients or family members

Key exclusion criteria

1.Patients having malignancy, severe heart diseases and other factors that would influence the results.
2.Chronic respiratory diseases e.g. BA, COPD
3.Without agreement of patients or family members

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshinobu Takemoto

Organization

Tagami memorial hospital

Division name

Internal medicine

Zip code


Address

Nisibeppucho 1779, Kagoshima City

TEL

099-282-0051

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yoshinobu Takemoto

Organization

Tagami memorial hospital

Division name

Internal medicine

Zip code


Address

Nisibeppucho 1779, Kagoshima City

TEL

099-282-0051

Homepage URL


Email

yoshinobu_takemoto@shunpukai.com


Sponsor or person

Institute

Dept. of traditional Asian medicine, Postgraduate school of medicine, Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Yonezawa hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Tagami memorial Hospital, Kagoshima Prefacture, National Yonezawa hospital, Yamagata Pref


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://jglobal.jst.go.jp/public/20090422/201102220184329522

Number of participants that the trial has enrolled


Results

Hangekobokuto improved the swallowing refex and decrease the pneumonia onset.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 07 Month 16 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date

2011 Year 01 Month 01 Day

Date of closure to data entry

2011 Year 02 Month 01 Day

Date trial data considered complete

2011 Year 03 Month 01 Day

Date analysis concluded

2011 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 09 Month 17 Day

Last modified on

2012 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005083


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name